Results 261 to 270 of about 234,919 (306)
Some of the next articles are maybe not open access.

Helicobacter pylori

Current Opinion in Internal Medicine, 2003
Helicobacter pylori is an important human pathogen, responsible for most peptic ulcer disease, gastritis and gastric malignancies. H. pylori has several unique features: it is highly adapted for gastric colonization, yet it produces clinical consequences in a small minority, its genome is known, and it is the only bacterium strongly associated with ...
Steven F, Moss, Shivani, Sood
openaire   +2 more sources

Helicobacter pylori

Current Opinion in Gastroenterology, 2014
This review focuses on new treatment options for eradicating Helicobacter pylori that have emerged as a result of decreased efficacy of standard triple therapy due to increasing antibiotic resistance. We also report on new data regarding primary and secondary gastric cancer prevention strategies and the potential role of H.
Peter, Malfertheiner, Michael, Selgrad
openaire   +2 more sources

Helicobacter and lymphoma

Der Chirurg, 1998
The gastrointestinal tract represents the most common extranodal site of malignant non-Hodgkin's lymphoma. Epidemiological, histomorphological, molecular biological and experimental animal studies undoubtedly underline the important role of Helicobacter pylori for the development and progression of primary gastric lymphoma of MALT (mucosa-associated ...
openaire   +2 more sources

Helicobacter Pylori

Scandinavian Journal of Gastroenterology, 1991
Helicobacter pylori is a unique pathogen and the leading cause of chronic gastric inflammation. For many individuals the organism is of low virulence, causing only mild inflammation and generating few, if any, dyspeptic symptoms. For those with more severe inflammation, H. pylori infection may be causal in the generation of dyspeptic symptoms.
G N, Tytgat, L, Noach, E A, Rauws
openaire   +2 more sources

Helicobacter pylori

Der Gastroenterologe, 2009
Helicobacter pylori is associated with various gastroduodenal diseases such as peptic ulcer, functional dyspepsia, MALT lymphoma and distal gastric cancer. Diagnosis of H. pylori can be established by non-invasive ((13C)urea breath test, stool antigen test, serology) and invasive (histology, rapid urease test, culture) tests.
openaire   +2 more sources

Helicobacter pylori

Die Innere Medizin
Helicobacter pylori was first characterized as an obligate bacterial pathogen in 1983. Since then, substantial advances have been made in understanding the pathophysiology of H. pylori infection, optimizing diagnostic and therapeutic strategies, and expanding testing and treatment-including in the prevention of gastric malignancies.
Christian, Schulz, Kerstin, Schütte
openaire   +2 more sources

Comparison of isolates of Helicobacter pylori and Helicobacter mustelae

Journal of Clinical Microbiology, 1991
On the basis of analysis of protein profiles, isolates of Helicobacter pylori and Helicobacter mustelae were less than 40% similar. Cytotoxin produced by H. pylori was not detected in isolates of H. mustelae. Both bacterial species agglutinated human erythrocytes. These results substantiate a taxonomic difference between H. pylori and H. mustelae.
D R, Morgan, J G, Fox, R D, Leunk
openaire   +2 more sources

Helicobacter Pylori

Current Treatment Options in Gastroenterology, 1999
All infected patients with a peptic ulcer should be treated for H. pylori. The role of treating H. pylori in patients with undiagnosed dyspepsia or non-ulcer dyspepsia, those taking nonsteroidal anti-inflammatory medications, or with a family history of gastric cancer remains controversial.
openaire   +2 more sources

HELICOBACTER, HELICOBACTER EVERYWHERE, AND NOT A DROP TO DRINK!

Journal of Pediatric Gastroenterology and Nutrition, 1992
B, Drumm, P, Sherman
openaire   +2 more sources

Helicobacter and atherosclerosis

American Heart Journal, 1999
J G, Kusters, E J, Kuipers
openaire   +2 more sources

Home - About - Disclaimer - Privacy